BioNexus Gene Lab
BGLC
BGLC
4 hedge funds and large institutions have $58.2K invested in BioNexus Gene Lab in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$37.1K |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$6K |
| 3 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
+$4.62K |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$13K |
| 2 |
HF
HRT Financial
New York
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $37.1K | +$37.1K | +8,331 | New |
|
2
Geode Capital Management
Boston,
Massachusetts
| $10.5K | – | – | – |
|
|
3
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $6K | +$6K | +1,296 | New |
|
|
SRL
4
Scientech Research LLC
Jersey City,
New Jersey
| $4.62K | +$4.62K | +1,039 | New |
|
|
VF
5
Virtu Financial
New York
| – | -$13K | -2,737 | Closed |
|
|
HF
6
HRT Financial
New York
| – | -$6K | -1,467 | Closed |
|